IRIS
BONANNI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.154
EU - Europa 10.514
AS - Asia 9.316
SA - Sud America 1.529
Continente sconosciuto - Info sul continente non disponibili 979
AF - Africa 160
OC - Oceania 22
Totale 38.674
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.721
SG - Singapore 3.703
IT - Italia 2.461
CN - Cina 2.439
RU - Federazione Russa 1.734
IE - Irlanda 1.346
BR - Brasile 1.202
UA - Ucraina 1.152
VN - Vietnam 939
GB - Regno Unito 885
TR - Turchia 819
SE - Svezia 788
DE - Germania 687
FR - Francia 580
IN - India 447
FI - Finlandia 332
BD - Bangladesh 250
CA - Canada 236
HK - Hong Kong 217
AR - Argentina 115
JP - Giappone 100
MX - Messico 98
NL - Olanda 94
PL - Polonia 86
ES - Italia 70
AT - Austria 67
IQ - Iraq 67
ZA - Sudafrica 64
EC - Ecuador 51
CZ - Repubblica Ceca 48
CO - Colombia 42
ID - Indonesia 41
PK - Pakistan 34
VE - Venezuela 32
IR - Iran 30
BE - Belgio 29
CL - Cile 28
KR - Corea 26
LU - Lussemburgo 26
JM - Giamaica 23
UZ - Uzbekistan 23
PE - Perù 21
MA - Marocco 20
EU - Europa 19
LT - Lituania 19
SA - Arabia Saudita 19
JO - Giordania 18
PY - Paraguay 17
AE - Emirati Arabi Uniti 16
IL - Israele 16
EG - Egitto 15
RO - Romania 15
AU - Australia 14
CH - Svizzera 14
MY - Malesia 14
CR - Costa Rica 13
PH - Filippine 13
TN - Tunisia 13
DK - Danimarca 12
EE - Estonia 12
AZ - Azerbaigian 11
HN - Honduras 11
DZ - Algeria 10
KE - Kenya 10
OM - Oman 10
PT - Portogallo 10
GT - Guatemala 9
LB - Libano 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
NO - Norvegia 8
NZ - Nuova Zelanda 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
GR - Grecia 6
KZ - Kazakistan 6
NI - Nicaragua 6
NP - Nepal 6
SN - Senegal 6
BG - Bulgaria 5
ET - Etiopia 5
HU - Ungheria 5
PA - Panama 5
AL - Albania 4
AM - Armenia 4
GY - Guiana 4
KH - Cambogia 4
NG - Nigeria 4
PS - Palestinian Territory 4
SC - Seychelles 4
SI - Slovenia 4
SV - El Salvador 4
TH - Thailandia 4
KG - Kirghizistan 3
LV - Lettonia 3
QA - Qatar 3
SM - San Marino 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
Totale 37.667
Salva come PNG Salva come JPEG
Città #
Singapore 2.690
San Jose 2.033
Chandler 1.491
Jacksonville 1.345
Dublin 1.323
Ashburn 1.044
Council Bluffs 798
Dallas 640
Princeton 621
Beijing 594
Southend 570
Los Angeles 425
Izmir 419
Nanjing 409
Santa Clara 330
Ho Chi Minh City 306
Dearborn 290
Wilmington 275
New York 263
The Dalles 242
Cambridge 213
Chieti 205
Hanoi 202
Buffalo 198
Altamura 195
Hong Kong 194
Munich 191
Tongling 159
Ann Arbor 144
Nanchang 139
Rome 133
Pescara 124
São Paulo 123
Boardman 116
Moscow 114
Redondo Beach 112
Milan 108
Orem 90
Woodbridge 77
Helsinki 76
Tokyo 76
Toronto 72
Phoenix 71
Tianjin 71
Washington 71
Columbus 70
Hebei 69
Atlanta 67
Chicago 67
Houston 67
Warsaw 67
Montreal 65
Denver 64
Brooklyn 63
Shenyang 61
Kunming 57
London 56
Chennai 55
Turku 54
Frankfurt am Main 53
Nuremberg 51
Hefei 50
Grevenbroich 49
Jiaxing 45
Seattle 45
Norwalk 44
Belo Horizonte 42
Changsha 41
Da Nang 41
Stockholm 41
Johannesburg 40
Haiphong 39
San Francisco 39
Mexico City 38
Poplar 38
Florence 36
Hangzhou 36
Jinan 35
Dong Ket 34
Amsterdam 33
Kimball 33
Manchester 33
Brno 30
Augusta 29
Naples 29
Rio de Janeiro 29
Biên Hòa 28
Boston 28
Mount Pleasant 28
Vienna 28
Capurso 26
Brasília 25
Falls Church 24
New Delhi 24
Pune 24
Baghdad 23
Brussels 23
Lanzhou 23
Mumbai 23
Paris 23
Totale 21.667
Salva come PNG Salva come JPEG
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.232
Emergenza neurologica - tempesta distonica: diagnosi e terapia 504
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 317
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 291
Diaphragmatic myoclonus due to SARS-CoV-2 infection 260
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 210
Pre-trattamento antiematico per Test/terapia all'apomorfina 203
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 201
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 195
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 192
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 189
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 184
Akinetic crisis in Dementia with Lewy Bodies 178
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 177
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 174
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 173
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 172
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 172
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 171
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 170
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 169
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 169
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 167
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 164
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 163
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 163
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 163
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 162
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 161
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 160
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 159
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 158
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 158
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 158
Improving diagnostic accuracy of DLB: An MRI study 158
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 158
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 157
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 155
Progetto atrofia multisistemica: risultati preliminari. 155
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 153
Bipallidal lesions induce delayed and progressive parkinsonism 153
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 153
Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer's disease 151
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 151
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 150
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 150
A stage-based approach to therapy in parkinson’s disease 150
Autoscopic phenomena: case report and review of literature. 148
Attention network in AD and DLB patients: a resting fMRI study. 148
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 145
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 144
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 143
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 143
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 143
ECG monitoring of post-stroke occurring arrhythmias: an observational study using 7-day Holter ECG 143
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 142
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel 141
Correlazione tra dinamica del repertorio TCR e reattività alla proteina basica della mielina (MBP) nel sangue periferico di pazienti con Sclerosi multipla esacerbante/remittente 140
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 140
Instabilità posturale nel Parkinson non farmaco-responder 139
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 139
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 137
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 136
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 136
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 136
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 136
"Occipital Pole" Sign on 18F-FDG PET for Dementia With Lewy Bodies and Posterior Cortical Atrophy: Evidence From the Treviso Dementia (TREDEM) Registry 136
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 135
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 135
Atrofia Multisistemica: approccio diagnostico multidisciplinare 134
Catamenial end-off dose in Parkinson's disease 134
Medio-dorsal thalamus and confabulations: Evidence from a clinical case and combined MRI/DTI study 134
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 133
Pathological Gambling in PD is reduced by Amantadine 133
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 133
Decrease in a Leak Conductance Associated with Mitochondrial Complex V and Improved Bioenergetic Efficiency may Underlie Cytoprotection of at-Risk Neurons by Dexpramipexole 133
EEG abnormalities in patients with delirium as a predictive biomarker of dementia with Lewy bodies 132
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 132
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase 132
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 132
Brainstem evoked potentials and magnetic resonance imaging abnormalities in differential diagnosis of intracranial hypotension. 132
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 132
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 132
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 131
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium 131
Mitochondrial Involvement in Neurodegenerative Dementia 130
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 130
Intermittent light stimulation in on-demand streaming television series, accuracy of information and seizure occurrence. The stream-light study 129
Regulation of Socs-1 and Gerp/TRIM-8 expression on multiple sclerosis patients undergoing interferon beta-1 treatment 129
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 129
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease 128
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. 128
Somatization in Parkinson's Disease: A systematic review 128
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 128
A multicentre validation study of the diagnostic value of plasma neurofilament light 128
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 127
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 127
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 127
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 127
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients 127
Totale 16.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.251 0 0 0 158 77 45 46 117 121 53 198 436
2022/20234.307 353 597 289 438 382 841 278 297 546 60 109 117
2023/20242.361 175 71 169 95 148 655 499 130 37 91 51 240
2024/20255.465 303 919 827 146 155 236 254 286 468 348 612 911
2025/202613.193 959 442 1.252 1.654 1.123 760 1.951 724 1.943 1.013 934 438
2026/20272.590 309 777 644 860 0 0 0 0 0 0 0 0
Totale 38.674